{"id":446331,"title":"Multiple additions to the Prescription Drug List (PDL) [2025-10-30]: Notice - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T11:39:43.007000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-10-30.html?wbdisable=false","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-10-30] October 30, 2025 Our file number: 25-107098-682 The purpose of this Notice of Amendment is to announce the addition of belantamab mafodotin, bulevirtide, delgocitinib, deutivacaftor, elinzanetant,…","rawSnapshotUrl":"/api/snapshots/raw/446331","browseUrl":"https://replay.healtharchive.ca/job-6/20260103113943/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-10-30.html?wbdisable=false#ha_snapshot=446331","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}